Financials
- Market Capitalization 462.28 M
- Employee 67
- Founded 2012
- CEO N/A
- Website www.prothena.com
- Headquarter Ireland
- FIGI UNKNOWN
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2960 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.77 USD | -8.48% | -14.99% | -5.47% | +75.79% | 472.38 M USD | ||
| 2961 | VSTM Verastem, Inc. - Common Stock | 5.37 USD | -2.89% | +19.60% | +29.09% | +7.83% | 471.88 M USD | ||
| 2977 | STRO Sutro Biopharma, Inc. - Common Stock | 27.84 USD | -6.36% | -10.19% | -3.33% | +60.09% | 461.32 M USD | ||
| 2985 | RZLT Rezolute, Inc. - Common Stock | 4.74 USD | -0.21% | -4.05% | +11.27% | -10.90% | 456.43 M USD |
Frequently asked questions about Prothena Corporation plc - Ordinary Shares
What is the Prothena Corporation plc - Ordinary Shares stock price today?
The current price of Prothena Corporation plc - Ordinary Shares (PRTA) is 8.83. Over the past 24 hours, the stock has changed by -4.44%. Follow the PRTA chart for real-time price dynamics.
What is the stock ticker of Prothena Corporation plc - Ordinary Shares?
Prothena Corporation plc - Ordinary Shares trades under the ticker PRTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Prothena Corporation plc - Ordinary Shares stock going up?
PRTA has changed by -8.21% over the last week, +0.68% over the last month, and +37.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Prothena Corporation plc - Ordinary Shares net income for the last quarter?
Prothena Corporation plc - Ordinary Shares reported net income of 32.72 M for the last quarter. The previous quarter showed -21.59 M, which means net income changed by +251.56%.
How many employees does Prothena Corporation plc - Ordinary Shares have?
As of the latest available data, Prothena Corporation plc - Ordinary Shares has 67 employees. Workforce size can provide additional context about the company's scale and operations.
What is Prothena Corporation plc - Ordinary Shares EBITDA?
Prothena Corporation plc - Ordinary Shares EBITDA is 32.63 M, and its EBITDA margin is 61%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Prothena Corporation plc - Ordinary Shares stock?
You can buy Prothena Corporation plc - Ordinary Shares (PRTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Prothena Corporation plc - Ordinary Shares stock?
Investing in Prothena Corporation plc - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRTA chart and related analysis on metatrader.com as part of your research.